9th Annual Biomarkers Congress

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2010 Noninvasive detection of colorectal neoplasia (CRN) in inflammatory bowel disease (IBD) by stool DNA testing: a pilot study DDW New Orleans LA 2010
2. 2010 Acute effects of ethanol and aspirin on fecal blood levels: a study using HemoQuant. Gastroenterology 1985 May; 88(PART 2):1385.
3. 2010 HemoQuant detection of colorectal neoplasia. Rochester, Minnesota, Clinical Reviews 1985 Oct/Nov; 23-4.
4. 2010 Noninvasive detection of serrated colorectal polyps by stool assay of methylated vimentin and mutant BRAF genes. DDW New Orleans, LA 2010
5. 2009 Gastroenterology 2009 Jun; 136(7):2068-73. Epub 2009 Apr 18 Next-generation stool DNA testing: expanding the scope.
6. 2009 Identifying differentially regulated proteins as markers for colorectal neoplasia 57th ASMS Conference on Mass Spectrometry. Philadelphia PA May-June 2009.
7. 2009 Stool protein markers for colorectal cancer: identification of high-abundance candidates by mass spectroscopy. DDW 2009
8. 2009 The effectiveness of colonoscopy in reducing mortality from colorectal cancer. Ann Intern Med 2009 Jun 2; 150(11):817; author reply 819-20
9. 2009 Approach to the patient with occult gastrointestinal bleeding In: In: Yamada T, et al, editors.. Atlas of gastroenterology. 4th ed. Oxford; Hoboken: Wiley-Blackwell; 2009. p. 10-20
10. 2009 High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay Gastroenterology 2009 Feb; 136(2):459-70. Epub 2008 Oct 15
11. 2008 Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers. Clin Gastroenterol Hepatol 2008 Dec; 6(12):1385-8. Epub 2008 Jul 17
12. 2008 Approach to the patient with occult gastrointestinal bleeding In: Yamada T, editor. Principles of clinical gastroenterology. Chichester; Hoboken: Wiley-Blackwell; 2008. p. 152-69
13. 2008 Defining the soluble proteome of human stool. Gastroenterology 2008 Apr; 134(4 Suppl 1):A-674.
14. 2008 Stool DNA for detection of gastrointestinal neoplasia: effect of lesion site Gastroenterology April 2008; 134(4, Suppl 1):A-487.
15. 2008 Detection of colorectal neoplasia by stool DNA testing: high discrimination with multi-marker quantitation Gastroenterology April 2008; 134(4, Suppl 1):A-484
16. 2008 Treatment with 5-Aza-2 ' deoxycytidine and trichostatin a identifies the tachykinin pirecursor 1 (Tac1) gene as specifically hypermethylated in cholangiocarcinoma. Hepatology 2008 Oct; 48(4 Suppl S):1535
17. 2008 Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 2008 Oct 7; 149(7):441-50, W81.
18. 2007 Methylated genes as candidate markers for colorectal cancer screening linked to CpG island methylator phenotype Gastroenterology 2007; 132(4 Suppl 2):A313.
19. 2007 A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening Gastroenterology 2007; 132(4 Suppl 2):A-624
20. 2007 Stool DNA screening for colorectal neoplasia: prospective multicenter comparison with occult blood testing. Gastroenterology 2007; 132(4 Suppl 2):A-3
21. 2007 Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease. Mol Cancer Res 2007 Feb; 5(2):153-63.
22. 2007 Detection of colorectal disease by stool defensin assay: an exploratory study Clin Gastroenterol Hepatol 2007 Jul; 5(7):865-8. Epub 2007 May 24
23. 2007 Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma Clin Cancer Res 2007 Aug 15; 13(16):4740-9
24. 2007 A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening Clin Chem 2007 Sep; 53(9):1646-51.
25. 2007 Highly methylated genes in colorectal neoplasia: implications for screening Cancer Epidemiol Biomarkers Prev 2007 Dec; 16(12):2686-96
26. 2006 Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia Clin Gastroenterol Hepatol 2006 Feb; 4(2):212-8.
27. 2006 Gastrointestinal bleeding In: ACP medicine: a publication of the American College of Physicians. New York: WebMD; 2006. p. 828-36
28. 2006 Cronkhite-Canada syndrome: clinical outcomes and molecular features Gastroenterology 2006; 130:A219
29. 2006 Stool -defensin assay for colorectal cancer screening: feasibility analysis Gastroenterology 2006; 130:A274.
30. 2006 Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: a population-based, retrospective cohort study Am J Gastroenterol 2006 Aug; 101(8):1872-9. Epub 2006 Jun 22.
31. 2006 Improved marker combination for detection of de novo genetic variation and aberrant DNA in colorectal neoplasia. Clin Chem 2006 Dec; 52(12):2299-302. Epub 2006 Nov 02
32. 2006 A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening Cancer Epidemiol Biomarkers Prev 2006 Jun; 15(6):1115-9.
33. 2005 Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus Int J Cancer 2005 Sept 10; 116(4):584-91
34. 2005 Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2005 Apr; 14(4):830-4
35. 2005 Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study Clin Gastroenterol Hepatol 2005 Feb; 3(2):150-8.
36. 2005 In: Kasper DL, et al, editors. Harrison's principles of internal medicine. 16th Edition. New York: McGraw-Hill, Medical Pub. Division; 2005. p. 224-33. Diarrhea and constipation
37. 2005 Stool screening for colorectal cancer: Molecular approaches Gastroenterology 2005 Jan; 128(1):192-206
38. 2005 Stool DNA screening for colorectal cancer: prospective multicenter comparison with Hemoccul Gastroenterology 2005; 128(4, Suppl 2):A-63.
39. 2005 A dicriminant DNA marker panel for detection of colorectal adenomas (Abstract 1083). Am J Gastroenterol 2005 Sep; 100(9 Suppl):S393.
40. 2005 Molecular-based stool screening for colorectal neoplasia Gastrointestinal Endoscopy 2005.
41. 2004 Hypermethylation silences GATA4 gene and occurs early in the tumorigenesis of Barrett's esophagus Gastroenterology 2004; 126:A238
42. 2004 Colorectal adenocarcinoma In: Johnson LR, editor. Encyclopedia of gastroenterology. Volume 1. Amsterdam: Elsevier Academic Press; 2004. p. 457-66
43. 2004 Gastrointestinal bleeding In: Dale DC. ACP Medicine New York, NY: WebMD Professional Publishing; 2004. p. 828-36.
44. 2004 Comparison of the relative sensitivity of CT colonography and double-contrast barium enema for screen detection of colorectal polyps. Clinical Gastroenterology & Hepatology 2004 Apr; 2(4):314-21
45. 2004 False-Positive stool DNA results on colorectal cancer screening: yield from supracolonic evaluation Gastroenterology 2004; 126:A-58.
46. 2004 Aberrant promoter methylation silences secreted-frizzed related protein genes and occurs early during neoplastic progression of Barrett's esophagus. Gastroenterology 2004; 126:A-177
47. 2003 Extracolonic findings at CT colonography: Evaluation of prevalence and cost in a screening population Gastroenterology 2003 Apr; 124(4):911-6
48. 2003 Aberrant promoter methylation of sFRP1, sFRP2 and sFRP5 is a common epigenomic event in lung adenocarcinoma (Abstract P-280). Lung Cancer 2003 Aug; 41(Suppl 2):S163
49. 2003 Functional characterization of KFL11, a novel TGFbetta-regulated tumor suppressor for pancreatic cancer. Pancreatology 2003; 3:436.
50. 2003 Identification of diagnostic markers for colorectal cancer by expression analysis of human tumors. AACR 94th Annual Meeting Toronto, Ontario, Canada, April ( 2003; abstract).
51. 2003 Approach to the patient with occult gastrointestinal bleeding. In: Yamada T, editor. Atlas of gastroenterology. 3rd Edition. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 12-21
52. 2003 Approach to the patient with occult gastrointestinal bleeding In: Yamada T, editor. Textbook of gastroenterology. 4th Edition. Volume 1. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 724-38
53. 2003 Clinical aspects of sporadic colorectal cancer . In: Rustgi AK, editor. Gastrointestinal cancers: a companion to Sleisenger and Fordtran's gastrointestinal and liver disease. Edinburgh: Saunders; 2003. p. 379-405.
54. 2003 Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia. Am J Gastroenterol 2003 Oct; 98(10):2299-305.
55. 2003 Prospective blinded evaluation of computed tomographic colonography for screen detection of colorectal polyps Gastroenterology 2003 Aug; 125(2):311-9.
56. 2003 DNA integrity as a potential marker for stool-based detection of colorectal cancer. Clin Chem 2003 Jul; 49(7):1058-65
57. 2003 Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: Prospective assessment of patient perceptions and preferences. Radiology 2003 May; 227(2):378-84.
58. 2002 Stool screening for colorectal cancer: evolution from occult blood to molecular markers Clin Chim Acta 2002 Jan; 315(1-2):157-68
59. 2002 Detection of occult upper gastrointestinal tract bleeding: Performance differences in fecal occult blood tests Mayo Clin Proc 2002 Jan; 77(1):23-8
60. 2002 Contrast-enhanced CT colonography in recurrent colorectal carcinoma: Feasibility of simultaneous evaluation for metastatic disease, local recurrence, and metachronous neoplasia in colorectal carcinoma. AJR Am J Roentgenol 2002 Feb; 178(2):283-90
61. 2002 A prospective, blinded assessment of the impact of preoperative staging on the management of rectal cancer. Gastroenterology 2002 Jul; 123(1):24-32.
62. 2002 Colorectal cancer prevention and detection. Introduction. Gastroenterol Clin North Am 2002 Dec; 31(4)
63. 2002 Comparison of CT colonography with colonoscopy, flexible sigmoidoscopy, and fecal occult blood testing for screen-detection of colorectal polyps Radiology 2002 Nov; 225(Suppl P):444.
64. 2002 Novel use of hypermethylated DNA markers in stool for detection of colorectal cancer: a feasibility study. Gastroenterol 2002; 122:A40
65. 2002 Stool-based DNA tests for colorectal cancer: clinical potential and early results Reviews in Gastroenterological Disorders 2002; 2 Suppl 1:S20-6
66. 2001 Diarrhea and constipation In: Braunwald E, et al, editors. Harrison's Principles of Internal Medicine. 15th Edition. New York: McGraw-Hill, Medical Publishing Division; 2001. p. 241-50
67. 2001 Prospective blinded evaluation of the impact of transrectal ultrasound (TRUS) with guided fine needle aspiration biopsy (FNA) on management of rectal cancer. Gastrointest Endosc 2001 Apr; 53(5):AB181.
68. 2001 A search for germline APC mutations in early onset colorectal cancer or familial colorectal cancer with normal DNA mismatch repair. Genes, Chromosomes & Cancer 2001 Feb; 30(2):181-6
69. 2001 CT colonography without cathartic preparation: feasibility study. Radiology 2001 Jun; 219(3):693-8.
70. 2001 Discrete event simulation of the cost-effectiveness of colorectal cancer screening by a DNA-based stool test relative to current screening practice. Gastroenterology 2001 Apr; 120(5 Suppl 1):A.406
71. 2001 Altered stool DNA as a predictor of advanced neoplastic colonic polyps. Gastroenterol 2001; 120:A599.
72. 2000 Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool. Dig Dis Sci 2000 Mar; 45(3):494-9.
73. 2000 Association of Peutz-Jeghers-like mucocutaneous pigmentation with breast and gynecologic carcinomas in women. Medicine (Baltimore) 2000 Sep; 79(5):293-8.
74. 2000 Optimization of CT colonography technique: prospective trial in 180 patients. Radiology 2000 Sep; 216(3):704-11
75. 2000 Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy Am J Gastroenterol 2000 Oct; 95(10):2831-7.
76. 2000 Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 2000 Nov; 119(5):1219-27.
77. 2000 Fecal occult blood testing for iron deficiency: a reappraisal Dig Dis 2000; 18(2):75-82
78. 2000 Morphometric analysis of the mucocellular layer overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum Pathol 2000 Jan; 31(1):51-7.
79. 2000 Detection of pancreatic cancer by assay of high molecular weight DNA in stool: results of a pilot study Pancreas 2000 Nov; 21(4):469.
80. 2000 Synchronous colorectal carcinoma: presence and concordance of DNA mismatch repair enzyme expression Gastroenterology 2000 Apr; 118(4 Suppl 2 Part 1):A40
81. 2000 Universal detection of aerodigestive cancers by assay of nonapoptotic human DNA in stool Gastroenterology 2000 Apr; 118((4 Suppl 2 Part 1)):AGA A855
82. 2000 Care of patients and their families with familial adenomatous polyposis Mayo Clin Proc 2000 Jan; 75(1):57-67.
83. 2000 Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis Gastroenterology 2000 May; 118(5):905-11
84. 1999 Screening by CT colography: too early to pass judgment on a nascent technology. Gastrointest Endoscopy 1999; 50:437-40
85. 1999 Innovative techniques for colorectal cancer screening Primary Care & Cancer 1999; 19(6):10-4.
86. 1999 Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy Mayo Clin Proc 1999 Dec; 74(12):1207-13.
87. 1999 Morbidity and Mortality Weekly Report 1999; 48(32):714-16. Gut 1999 Mar; 44(3):301-5
88. 1999 Evaluation of the performance characteristics of fecal occult blood tests in the setting of occult gastrointestinal bleeding. Ir J Med Sci 1999 Oct Nov Dec; 168(Suppl 9):21
89. 1999 Evaluation of an enzyme-linked immunoassay (EIA) for the detection of Helicobacter pylori antigen in stools General Meeting of the American Society for Microbiology 1999; 99:116-7
90. 1998 Mechanisms of colorectal carcinogenesis differ within individuals: comparison of MLH1 and MSH2 expression in initial and metachronous primaries Am J Gastroenterol 93:1684, 1998.
91. 1998 Characterization of aberrant crypt foci in human colectomy specimens Gastroenterology 114:A700, 1998
92. 1998 Evaluation of an enzyme-linked immunoassay (EIA) for the detection of Helicobacter pylori antigen in stools Am J Trop Med Hyg 1998 Sep; 59(3 Suppl):356
93. 1998 Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case-control study Cancer 1998 Mar 1; 82(5):822-6.
94. 1998 Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 1998 Jun 1; 128(11):896-9.
95. 1998 Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 1998 Nov; 115(5):1079-83
96. 1997 Band ligation-assisted endoscopic resection of a flat rectal adenoma containing infiltrating adenocarcinoma. Band ligation-assisted endoscopic resection of a flat rectal adenoma containing infiltrating adenocarcinoma.
97. 1997 Computed tomographic colography (virtual colonoscopy) for polyp detection: early comparison against barium enema. Gastroenterology 1997 Apr; 112(4 Suppl):A575.
98. 1997 Reducing data size and radiation dose for CT colonography. AJR Am J Roentgenol 1997 May; 168(5):1181-4
99. 1997 Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity. Radiology 1997 Oct; 205(1):59-65
100. 1997 Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA 1997 Apr 9; 277(14):1135-9
101. 1997 Fecal occult blood testing for colorectal cancer. Can we afford to do this? Gastroenterol Clin North Am 1997 Mar; 26(1):41-55
102. 1997 Evidence against flat dysplasia as a regional field defect in small bowel adenocarcinoma associated with celiac sprue. Mayo Clin Proc 1997 Apr; 72(4):320-2
103. 1997 Relevance of occult nodal metastases by immuno-detection in rectal cancer: a case-control study Gastroenterology 1997 Apr; 112(4 Suppl):A539
104. 1997 Blinded evaluation of colorectal polyp detection with compluted tomogrpahic colography (CTC, virtual colonoscopy). Society of Gastrointestinal Radiologists, Cancun, Mexico, March 9-14, 1997
105. 1996 Stool markers for colorectal cancer screening: future considerations. Dig Dis 1996 May-Jun; 14(3):132-44.
106. 1996 Feasibility of colorectal polyp detection by 2D and 3D helical CT AJR Am J Roentgenol 1996; 166(Suppl):84
107. 1996 Colorectal polyp detection with CT colography (virtual colonoscopy): a blinded, prospective study. Radiology 1996 Nov; 201(P Suppl):252.
108. 1996 2D and 3D visualization of colorectal polyps by helical CT: technique and clinical results AJR Am J Roentgenol 1996; 166(Suppl):214.
109. 1996 Colorectal polyp detection using computed tomographic colography (CTC, virtual colonoscopy): technical and clinical applications Radiology. Supplement 201(P):499, 1996
110. 1996 Detection of colorectal polyps by computed tomographic colography: feasibility of a novel technique Gastroenterology 1996 Jan; 110(1):284-90
111. 1996 Fecal hemoglobin excretion in elderly patients with atrial fibrillation: combined aspirin and low-dose warfarin vs conventional warfarin therapy Arch Intern Med 1996 Mar 25; 156(6):658-60.
112. 1996 Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin. Scand J Gastroenterol 1996 Oct; 31(10):1001-5.
113. 1995 Two year outcome study following tips: the Mayo clinic experience J Hepatol 1995; 23(Suppl 1):205.
114. 1995 Approach to the patient with occult gastrointestinal bleeding In: Yamada T, editor. Textbook of Gastroenterology. Second Edition. Volume 1. Philadelphia: J. B. Lippincott Company; 1995. p. 699-717.
115. 1995 Laparoscopically assisted panenteroscopy: a feasibility study in pig Gastrointest Endosc 1995 Feb; 41(2):154-6.
116. 1995 Rebleeding from peptic ulcers associated with adherent clots: a randomized controlled study comparing endoscopic and medical therapy. Gastrointest Endosc 1995; 41:360
117. 1995 Candidate stool markers for colorectal cancer screening: an immunohistochemical analysis. Gastroenterology 1995 Apr; 108(Suppl):A473
118. 1994 Increased fecal hemoglobin excretion in combined aspirin-low dose Warfarin versus adjusted dose Warfarin prophylaxis American Heart Association, 67th Scientific Sessions; Dallas, TX. 1994
119. 1994 Endoscopic treatment of major bleeding from advanced gastroduodenal malignant lesions. Endoscopic treatment of major bleeding from advanced gastroduodenal malignant lesions.
120. 1994 Does performance status influence the outcome of Nd:YAG laser therapy of proximal esophageal tumors? Gastrointest Endosc 1994 Jul-Aug; 40(4):451-4
121. 1994 Intraluminal measurement of enteric mucosal perfusion: relationship to superior mesenteric artery flow during basal and postprandial states in the dog. Surgery 1994 Jan; 115(1):118-26.
122. 1994 Gastrointestinal Laser Group. Endoscopic Nd:YAG Laser palliation of duodenal tumors Gastrointestinal Endoscopy 1994
123. 1994 Colorectal endoscopy Curr Opin Gastroenterol 1994; 10:41-48
124. 1994 Pandemic occult intestinal bleeding among Yupik Eskimos: Role of Helicobacter pylori. Presented at World Congress Meeting, Los Angeles, CA, October 2-7, 1994
125. 1994 Laparoscopically-assisted panenteroscopy: a feasibility study in pigs Gastrointest Endosc 1994 Mar/Apr; 40(Suppl):P17.
126. 1993 Endoscopic Nd:YAG laser coagulation of bleeding from radiation proctopathy Gastrointest Endosc 1993 Jul-Aug; 39(4):513-7
127. 1993 Endoscopic laser coagulation of radiation-induced mucosal vascular lesions in the upper gastrointestinal tract and proximal colon Am J Gastroenterol 1993 Aug; 88:1224-1227
128. 1993 Screening for colorectal cancer: The accuracy of fecal occult blood. JAMA 1993;270:451-3
129. 1993 Accuracy of fecal occult blood screening for colorectal neoplasia. JAMA 1993 Mar 10; 269:1262-1267
130. 1993 Rectal mucosectomy: a definitive approach to extensive hemangiomas of the rectum. J Pediatr Surg 1993 Mar; 28(3):379-81
131. 1993 Colonoscopy Curr Opin Gastroenterol 1993 Jan; 9:34-41.
132. 1993 Colorectal cancer screening. Rochester, Minnesota, Clinical Reviews 1993; 33-5.
133. 1992 Photodynamic therapy (PDT) and combination antibiotics to eradicate Helicobacter pylori (Hp) in vitro Am J Gastroenterol 87:145, 1992.
134. 1992 Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs Mayo Clin Proc 1992 Apr; 67(4):354-64
135. 1992 Acute gastrointestinal bleeding. Experience of a specialized management team J Clin Gastroenterol 1992 Apr; 14(3):260-7
136. 1992 Long-term nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology 1992 Jun; 102(6):1899-905
137. 1992 The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol 1992 Oct; 15(3):256-63.
138. 1992 Possible role of transforming growth factor alpha in the pathogenesis of Menetrier's disease: supportive evidence form humans and transgenic mice. Gastroenterology 1992 Dec; 103(6):1950-63
139. 1992 Light dosimetry in photodynamic therapy for Helicobacter pylori. Int Congr Ser 1992; 1011:281-5
140. 1992 Colorectal cancer screening: obstacles and opportunities. Rochester, Minnesota, Clinical Reviews 1992; 108-9
141. 1992 Photodynamic therapy and combination antibiotics to eradicate Helicobacter pylori in vitro. American College of Gastroenterology, October 1992
142. 1992 Approach to the patient with occult gastrointestinal bleeding In: Yamada T, editor. Atlas of Gastroenterology. Philadelphia: J. B. Lippincott Company; 1992. p. 6-12
143. 1992 Light dosimetry in photodynamic therapy for helicobacter pylori In: P. Spinelli, M. Fanti, and R. Marchesini. Photodynamic Therapy and Biomedical Lasers. Elsevier Science Publishers B.V.; 1992
144. 1992 Ileal Kock Pouch Obstruction Secondary to Retained Medicoliths. Gastrointestinal Endoscopy 1992; 38:613-4
145. 1992 Occult blood screening: Obstacles to effectiveness Cancer 5 1992; 70:1259-65.
146. 1991 Screening for colorectal disease In: Phillips SF, Pemberton JH, Shorter RG, editors. The Large Intestine: Physiology, Pathophysiology, and Disease. New York: Raven Press; 1991. p. 335-55
147. 1991 Occult Gastrointestinal Bleeding In: T Yamada. Textbook of Gastroenterology. New York, NY: J B Lippincott, Co.; 1991. p. 616-34
148. 1991 Approach to the patient with occult gastrointestinal bleeding In: Tadataka Y, et al, editors. Textbook of Gastroenterology. Volume 1. Philadelphia: J. B. Lippincott Co.; 1991. p. 616-33.
149. 1991 Validity of fecal blood (fb) screening: HemoQuant (hqt) versus Hemoccult (ho). Gastroenterology 1991; 100(PART 2 OF 2 PARTS):May.
150. 1991 Comparison of molecular genetic abnormalities in primary and metastatic colorectal cancer. Gastroenterology 1991 May; 100(PART 2 OF 2 PARTS):A408.
151. 1991 The mechanisms and prevention of intravascular fluid loss after occlusion of the supraceliac aorta in dogs J Vasc Surg 1991 May; 13(5):637-45.
152. 1991 Epidemiology, etiology, diagnosis, and screening colorectal neoplasia Curr Opin Gastroenterol 1991 Feb; 7:18-24.
153. 1991 Detecting occult GI bleeding and its cause Contemp Int Med 1991; 3:17-29
154. 1990 The Mechanisms and prevention of intravascular fluid loss following occlusion of the supraceliac aorta in dogs Midwestern Vascular Surgical Society, Nov 1990
155. 1990 Colorectal cancer detection in the practice setting. Impact of fecal blood testing Arch Intern Med 1990 May; 150(5):1041-5.
156. 1990 Recent trends in the diagnosis and management of chronic intestinal ischemia. Ann Vasc Surg 1990 Mar; 4(2):126-32.
157. 1990 Colorectal neoplasia: Diagnosis and screening Current opinions in Gastroenterology 6:33-37, 1990
158. 1990 Does performance status influence the outcome of Nd: YAG laser therapy of proximal esophageal tumors? Gastrointest Endosc 1990; 36:187.
159. 1989 Prospective comparison of contact with noncontact Nd:Yag laser therapy for palliation of esophageal carcinoma Gastrointest Endosc 1989 Sep-Oct; 35(5):394-7.
160. 1989 Early clinical and endoscopic observations of a GI bleeding team with acutely bleeding peptic ulcers. Am J Gastroenterol 84:1160, 1989.
161. 1989 Watermelon stomach (wms): clinical features and response to endoscopic laser therapy. Gastrointest Endosc 1989; 96:178.
162. 1989 Chromosome 5q alleles not lost in colorectal carcinomas from patients with HNPCC Am J Gastroenterology 1989;96:A96.
163. 1989 Chromosome 17p allele loss in multiple colorectal carcinomas from a patient with polyposis coli. UCLA Symposia on Molecular Biology, 1989.
164. 1989 Chromosome 17p allele loss in multiple colorectal carcinoma from a patient with polyposis coli J Cell Biochem Supp 1989; 13B:27
165. 1989 HemoQuant and the detection of colorectal cancer Proceedings of the 2nd International Conference on Gastrointestinal Cancer, Jerusalem, Israel 1989
166. 1989 Mayo Clinic and North Central Cancer Treatment Group. Fecal occult blood is an insensitive marker for locally recurrent colorectal cancer 2nd International Conference on Gastrointestinal Cancer 1989; 1
167. 1989 Clinical presentation of colorectal cancer: impact of fecal blood testing. Gastroenterology 1989; 96:4
168. 1989 Localization of hematoporphyrin. Derivative to human colorectal cancer. Cancer 1989 Oct 15; 64(8):1569-76.
169. 1989 Endoscopic gastric vagotomy: a feasibility study using laser in dogs. Gastrointest Endosc 1989 Sep-Oct; 35(5):419-24.
170. 1989 Endoscopic laser therapy for watermelon stomach. Gastroenterology 1989 Jun; 96(6):1462-5
171. 1989 Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer 1989 May 1; 63(9):1826-30.
172. 1989 Chromosome 5q alleles not lost in colorectal carcinomas from patients with hereditary non-polyposis colorectal cancer. Gastroenterology 1989; 96:A91.
173. 1988 Fecal blood testing: demystifying the occult. In: Levin B, editor. Gastrointestinal Cancer: Current Approaches to Diagnosis and Treatment Volume 30. Austin: University of Texas Press; 1988. (Annual Clinical Conference on Cancer.). p. 31-50.
174. 1988 Cancer control research in the North Central Cancer Treatment Group (NCCTG). In: Engstron PF, editor. Advances in Cancer Control VI. New York: Alan R. Liss, Inc.; 1988. p. 345-53
175. 1988 Fecal blood tests Check Sample 26:1-5, 1988
176. 1988 A stool collection device: The first step in occult blood testing. Ann Int Med 1988; 108:609-12
177. 1988 Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative Lasers in Surgery & Medicine 1988; 8(3):294-300
178. 1988 Measurement of degraded fecal hemoglobin-heme to estimate gastrointestinal site of occult bleeding. Appraisal of its clinical utility. Dig Dis Sci 1988 May; 33(5):605-8
179. 1988 Mucosal vascular malformations of the gastrointestinal tract: clinical observations and results of endoscopic neodymium: yttrium-aluminum- garnet laser therapy. Mayo Clin Proc 1988 Oct; 63(10):993-1003
180. 1988 Assessment of intestinal ischemia by endoscopic measurement of mucosal perfusion: a pilot study in dogs. Gastroenterology 1988 May; 94(PART 2):A251.
181. 1988 Endoscopic laser therapy for watermelon stomach Lasers Surg Med 1988 Apr 25-27; 8:165
182. 1988 Cancer control research in the North Central Cancer Treatment Group (NCCTG). Advances in Cancer Control 1988 Mar; 1:13
183. 1988 Endoscopic laser vagotomy: structural considerations and preliminary experience in the dog. Gastrointest Endosc, 1988.
184. 1988 Functional assessment of intestinal ischemia by postcibal measurement of mucosal perfusion Am J Gastro 83:135, 1988.
185. 1987 Prospective comparison of contact with non-contact nd:Yag laser therapy for palliation of esophageal carcinoma Lasers Surg Med 1987; 7:110.
186. 1987 Routine use of HemoQuant test for fecal blood in clinical practice: analysis of performance Am J Clin Pathol 1987; 88:532
187. 1987 Prospective study of skin light sensitivity from hematoporphyrin derivative Lasers Surg Med 1987; 7:106. (Abstract)
188. 1987 Longitudinal patterns of occult bleeding in colorectal cancer. Gastroenterology 1987 May; 92(PART 2):1290.
189. 1987 Ahlquist DA, Fleming JL, McGill DB, Moertel CG, Schwartz S, Wieand HS, Rubin J Gastroenterology 1987 May; 92(PART 2):1291
190. 1987 Selective affinity of hematoporphyrin derivative to colorectal cancer Gastroenterology 1987 May; 92(PART 2):1699.
191. 1987 Automated trial management in a multicenter cancer control study. Control Clin Trials 1987 Sep; 8:301
192. 1987 The HemoQuant test for fecal blood: an update In:. Rochester, Minnesota, Clinical Reviews 1987 Oct/Nov; 29-30
193. 1987 Endoscopic laser palliation of malignant dysphagia: a prospective study Mayo Clin Proc 1987 Oct; 62(10):867-74.
194. 1987 Demystification of the occult with HemoQuant. Gastroenterol Clin Biol 1987 Mar; 11(3):191-3
195. 1986 The relationship between drug-induced gastroduodenal injury and fecal blood loss Gastroenterology 1986 May; 90(PART 2):1511
196. 1986 Fecal blood testing in microcytic anemia: comparison of HemoQuant with Hemoccult. Gastroenterology 1986 May; 90(PART 2):1417.
197. 1986 Localization of hematoporphyrin derivative in colorectal neoplasia Lasers Surg Med 1986; 6:192.
198. 1986 Mayo laser experience in upper and lower gut vascular malformations Lasers Surg Med 1986; 6:195
199. 1986 Tests for fecal occult blood in the detection of colorectal cancer. In: Beahrs OH, Higgins GA, Weinstein JJ, editors. Colorectal Tumors. Philadelphia: J. B. Lippincott Co.; 1986. p. 39-47.
200. 1986 Laser therapy for severe radiation-induced rectal bleeding Mayo Clin Proc 1986 Dec; 61(12):927-31
201. 1986 Fecal blood levels in health and disease: a study using HemoQuant N Engl J Med 1986 Feb 6; 314:388-389.
202. 1986 Defects in prostaglandin synthesis and metabolism in ulcer disease Dig Dis Sci 1986 Feb; 31(2 Suppl):20S-27S
203. 1986 Localization of hematoporphyrin derivative in colorectal neoplasia Gastroenterology 1986 May; 90(PART 2):1669.
204. 1986 Measurement of degraded fecal hemoglobin by HemoQuant to estimate the gastrointestinal site of occult bleeding Gastroenterology 1986 May; 90(PART 2):1431
205. 1985 Use of fecal occult blood tests in the detection of colorectal neoplasia In: Thomas F. Nealon, Jr. Problems in General Surgery Vol. 2. Philadelphia: Lippincott Co; 1985. p. 200-10
206. 1985 HemoQuant--An Approach to Screening for Fecal Occult Blood In: Mastormarion AJ. Carcinoma of the Large Bowel and its Precursors Alan R. Liss, Inc.; 1985. p. 45-56
207. 1985 Fecal blood levels in health and disease: A study using HemoQuant. N Eng J Med 1985; 312:1422-28
208. 1985 Hemoquant--an approach to screening for fecal occult blood Progress in Clinical & Biological Research 1985; 186:45-56.
209. 1985 Fecal blood levels in health and disease. A study using HemoQuant. N Engl J Med 1985 May 30; 312(22):1422-8
210. 1984 Applications of laser treatment to gastrointestinal lesions In:. Rochester, Minnesota, Clinical Reviews 1984 Oct/Nov; 69-70
211. 1984 HemoQuant test for occult blood: the Sherlock Holmes test? Mayo Clin Proc 1984 Nov; 59(11):766-8
212. 1984 HemoQuant, a new quantitative assay for fecal hemoglobin. Comparison with Hemoccult Ann Intern Med 1984 Sep; 101(3):297-302.
213. 1984 Gastrointestinal blood loss and anemia in runners. Ann Intern Med 1984 Jun; 100(6):843-5.
214. 1984 Glycerol metabolism in the hibernating black bear. J Comp Physiol [B] 1984; 155:75-79
215. 1983 A new quantitative assay for fecal hemoglobin, HemoQuant: analyses in health and GI disease. Gastroenterology 1983 May; 84(PART 2):1089.
216. 1983 The HemoQuant test: a specific and quantitative determination of heme (hemoglobin) in feces and other materials Clin Chem 1983 Dec; 29(12):2061-7
217. 1983 Factors influencing metabolism of arachidonic acid in guinea pig gastric mucosa Am J Physiol 1983 Feb; 244(2):G131-7.
218. 1983 HemoQuant, a new quantitative assay for fecal hemoglobin: comparison with Hemoccult. Clin Chem 1983; 29:2067.
219. 1983 Duodenal prostaglandin synthesis and acid load in health and in duodenal ulcer diseas Gastroenterology 1983 Sep; 85(3):522-8.
220. 1983 HemoQuant, a new quantitative assay for fecal hemoblogin: comparison with Hemoccult. Clin Res 1983 Apr; 31:474A.
221. 1982 Modification and evaluation of the Jaffe-Zierdt stool occult blood test. Clin Chem 1982; 28:1584.
222. 1982 Prostaglandin generation from gastroduodenal mucosa: regional and species differences Prostaglandins 1982 Jul; 24(1):115-25
223. 1981 Duodenal prostaglandin synthesis and postprandial acid in duodenal ulcer. Clin Res 1981 Oct; 29:710A
224. 1981 Factors influencing prostaglandin (PG) synthesis in mammalian gastroduodenal mucosa Gastroenterology 1981 May; 80(PART 2):1098.
225. 1980 Pseudoinsulinoma syndrome from inadvertent tolazamide ingestion. Ann Intern Med 1980 Aug; 93(2):281-2.
226. 1976 Glycerol and alanine metabolism in the hibernating black bear. Physiologist 1976 Aug; 19:107. (Abstract)
227. 1975 Use of leuco-dyes in the quantitative micro-determination of hemoglobin and other heme compounds Clin Chem 1975; 21:362-369.
228. 1975 Iron deficiency anemia in Alaska native children, Hooper Bay, AK, 1999 Morbidity and Mortality Weekly Report 1999; 48(32):714-16.


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.